Our findings demonstrated that mRNA vaccine (BNT162b2) effectively induced antigen-specific CD4+ and CD8+ memory T cells, as well as anti-RBD IgGs and neutralizing antibodies in all vaccinees regardless of the presence of type 2 diabetes. This evidence concerns the gene CD4 and type 2 diabetes mellitus.